ISSN: 2161-1149 (Printed)
+44-77-2385-9429
Department of Arthritis, University of Cambridge, Cambridge, United Kingdom
Commentary
For What Reason is the Development of Disease-Modifying Osteoarthritis Drugs (DMOADs) Required?
Author(s): Little Hunter*
DOI:
10.37421/2161-1149.2021.11.291